VNDA News 13.58 Vanda Pharmaceuticals Inc (VNDA)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Vanda Pharmaceuticals Inc (VNDA) 13.58 $VNDA

Healthcare Companies Report Product Availability, Earning Release Schedules, Event, and Stock Movements - Analyst Notes on Celgene, Vanda, Chelsea Therapeutics, Neurocrine Biosciences, and USANA
PR Newswire - Mon Apr 14, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Celgene Corporation (NASDAQ: CELG), Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA), Chelsea Therapeutics International Ltd. (NASDAQ: CHTP), Neurocrine Biosciences Inc. (NASDAQ: NBIX), and USANA Health Sciences Inc. (NYSE: USNA). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/1050-100free

Vanda Pharmaceuticals Announces Availability of HETLIOZ(TM) (tasimelteon) for Non-24-Hour Sleep-Wake Disorder (Non-24)
PR Newswire - Wed Apr 09, 6:00PM CDT
Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) today announced the availability of HETLIOZ(TM). HETLIOZ(TM) is the first treatment approved by the U.S Food and Drug Administration (FDA) for Non-24-Hour Sleep-Wake Disorder (Non-24), a serious chronic circadian rhythm disorder that affects up to 70 percent of people who are totally blind.

Vanda Pharmaceuticals Shares Up 22.5% Since SmarTrend's Buy Recommendation (VNDA)
Comtex SmarTrend(R) - Tue Apr 08, 11:10AM CDT
SmarTrend identified an Uptrend for Vanda Pharmaceuticals (NASDAQ:VNDA) on December 30th, 2013 at $12.50. In approximately 3 months, Vanda Pharmaceuticals has returned 22.53% as of today's recent price of $15.31.

Vanda Pharmaceuticals Has Returned 33.8% Since SmarTrend Recommendation (VNDA)
Comtex SmarTrend(R) - Tue Apr 01, 9:43AM CDT
SmarTrend identified an Uptrend for Vanda Pharmaceuticals (NASDAQ:VNDA) on December 30th, 2013 at $12.50. In approximately 3 months, Vanda Pharmaceuticals has returned 33.81% as of today's recent price of $16.72.

Nasdaq stocks posting largest percentage increases
AP - Wed Mar 26, 12:16PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at 1 p.m.:

Pharma & Biotech Stock Outlook - March 2014 - Zacks Analyst Interviews
Arpita Dutt - Zacks Investment Research - Wed Mar 26, 1:17AM CDT
Pharma & Biotech Stock Outlook - March 2014 - Zacks Analyst Interviews

Pharma & Biotech Stock Outlook - March 2014 - Industry Outlook
Arpita Dutt - Zacks Investment Research - Wed Mar 26, 1:17AM CDT
Pharma & Biotech Stock Outlook - March 2014 - Industry Outlook

41.7% Return Seen to Date on SmarTrend Vanda Pharmaceuticals Call (VNDA)
Comtex SmarTrend(R) - Tue Mar 25, 9:18AM CDT
SmarTrend identified an Uptrend for Vanda Pharmaceuticals (NASDAQ:VNDA) on December 30th, 2013 at $12.50. In approximately 3 months, Vanda Pharmaceuticals has returned 41.74% as of today's recent price of $17.71.

Does Mannkind Offer a Good Risk to Reward Ratio?
George Budwell, The Motley Fool - Motley Fool - Fri Mar 21, 5:30PM CDT
It seems there is never a dull moment in the health care sector. On nearly a daily basis, some company is soaring to new heights or sinking like a stone. And most of the really big moves in the sector, up or down, are tied to a pivotal regulatory...

3 Stocks Near 52-Week Highs Worth Selling
Sean Williams, The Motley Fool - Motley Fool - Thu Mar 20, 3:25PM CDT
You might be compelled to think that territorial tensions between Russia and Ukraine and generally mixed economic data might push the market lower, but you'd be sorely mistaken. In fact, new highs are outpacing new lows by close to a 10-to-1 margin...

Breakfast Round-up - 52-Weeks High Reset: NextEra Energy, Silver Standard Resources, Wisconsin Energy, and Vanda Pharma
PR Newswire - Tue Mar 18, 8:39AM CDT
On Monday, March 17, 2014, the NASDAQ Composite finished at 4,279.95, up 0.81%. The Dow Jones Industrial Average closed the session at 16,247.22, up 1.13% and the S&P 500 ended the day at 1,858.83, higher by 0.96%. The gains were broad based as all the sectors ended the session in positive. Investor-Edge.com looks at some of the equities that hit a new 52-week high during the last session. These include NextEra Energy Inc. (NYSE:NEE), Silver Standard Resources Inc. (NASDAQ:SSRI), Wisconsin Energy Corporation (NYSE MKT: WEC), and Vanda Pharmaceuticals Inc. (NASDAQ:VNDA). Free research on these four companies can be accessed at:

Vanda Pharmaceuticals Up 44.3% Since SmarTrend Uptrend Call (VNDA)
Comtex SmarTrend(R) - Mon Mar 17, 5:19PM CDT
SmarTrend identified an Uptrend for Vanda Pharmaceuticals (NASDAQ:VNDA) on December 30th, 2013 at $12.50. In approximately 3 months, Vanda Pharmaceuticals has returned 44.30% as of today's recent price of $18.03.

Vanda Pharmaceuticals (VNDA) Soars: Stock Adds 9.6% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Mar 14, 8:21AM CDT
Vanda Pharmaceuticals, Inc. (VNDA) was a big mover last session, as the company saw its shares rise by roughly 10% on the day.

Vanda Pharmaceuticals Has Returned 21.1% Since SmarTrend Recommendation (VNDA)
Comtex SmarTrend(R) - Mon Mar 10, 11:11AM CDT
SmarTrend identified an Uptrend for Vanda Pharmaceuticals (NASDAQ:VNDA) on December 30th, 2013 at $12.50. In approximately 2 months, Vanda Pharmaceuticals has returned 21.09% as of today's recent price of $15.13.

Financial Results Releases and Schedules, Clinical Study Results, Partnerships, and Senior-Level Appointments - Analyst Notes on Arena, Horizon Pharma, Enanta, Vanda, and PTC
PR Newswire - Wed Mar 05, 2:30PM CST
Editor Note: For more information about this release, please scroll to bottom.

Shares of VNDA Up 20.6% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Mon Mar 03, 9:51AM CST
SmarTrend identified an Uptrend for Vanda Pharmaceuticals (NASDAQ:VNDA) on December 30th, 2013 at $12.50. In approximately 2 months, Vanda Pharmaceuticals has returned 20.61% as of today's recent price of $15.07.

Blind Adventurer, Erik Weihenmayer, Launches National Campaign to Raise Awareness of Non-24-Hour Sleep-Wake Disorder
PR Newswire - Fri Feb 28, 6:00AM CST
Vanda Pharmaceuticals Inc. (VANDA) (NASDAQ: VNDA) today announced that it has partnered with Erik Weihenmayer, a world-renowned adventurer and the only blind person to climb Mount Everest, to support the Non-24 Share More Campaign and launch the expert podcast series available at Non-24.com. This national education initiative aims to raise awareness for Non-24-Hour Sleep-Wake Disorder (Non-24), a serious, chronic circadian rhythm disorder that affects up to 70 percent of people who are totally blind.[1]

5 Monster Momentum Stocks to Trade
at The Street - Tue Feb 25, 1:23PM CST
Momentum traders and trend-following traders are basking in profits in this current market.

10-K: VANDA PHARMACEUTICALS INC.
Edgar Online - Tue Feb 25, 6:04AM CST
ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Automus and Google Cloud Put Agents to Work on Oracle

Updated Category News Views 96

Oracle back offices are where shiny AI promises go to earn their keep, or get buried under a mountain of integrations. Automus Consulting’s newly announced collaboration with Google Cloud, unveiled November 20 at Oracle AI World, is aimed squarely at that messy middle. The firm wants to combine its Oracle implementation experience with Google Cloud infrastructure and...

Continue Reading
Industrial Air Compressors: Fix, Rebuild, or Replace

Updated Category News Views 36

A compressor’s ugliest invoice is rarely the one from the service technician. It is the one nobody sees at first: a stalled production line, missed output, overtime, wasted electricity, and a maintenance crew chasing the same machine again next month. Pam Mahood of Waterloo, Iowa-based Compressed Air & Equipment Co. puts the decision where it belongs—not on the price...

Continue Reading
First Horizon Opens Its Charlotte Office in South End

Updated Category News Views 137

A Building Is Not a Balance Sheet Charlotte got a fresh First Horizon sign at 110 East Boulevard on Nov. 19, 2026, and that is a sensible move, not a magic trick. The bank has officially opened a corporate office in the city’s South End neighborhood, positioning the team to develop client relationships across the Charlotte area and broaden its regional footprint. That...

Continue Reading
CVRx Lawsuit Puts a Brutal 59.76% Drop Under Focus

Updated Category News Views 33

Sixty cents on the dollar vanished from CVRx in one trading day, and that kind of wreckage deserves more than a shrug. Shares fell $3.55, or 59.76%, to $2.39 on August 7, 2026, after the company disclosed a U.S. Department of Justice civil investigative demand in its August 6 Form 10-Q. For holders of NASDAQ:CVRX, the immediate question is not whether the chart looks...

Continue Reading
Cleveland Picks Golden Key for Citywide Leadership Training

Updated Category News Views 87

A Citywide Bet on Better Management Municipal management rarely grabs headlines until something breaks, which is precisely why Cleveland's decision to bring in Golden Key Group deserves a closer look. Announced November 20, 2026, the arrangement calls for GKG to design and deliver a citywide management training program through Cleveland's Department of Personnel and Human...

Continue Reading
Nvidia Lawsuit Allegations Put Disclosure Risk in Focus

Updated Category News Views 83

A lawsuit notice can turn a roaring chip story sour in a hurry, and this one deserves a cold, careful read rather than the usual internet stampede. DJS Law Group says it has filed a securities class action against NVIDIA, alleging that the company made materially false and misleading statements during a stated class period running from October 9, 2025 through November 8,...

Continue Reading
Mindgruve's Tech Hire Puts Sightline Growth in Focus

Updated Category News Views 67

Agency technology hires usually land with all the thunder of a stapler dropping, but this one deserves a closer look. Mindgruve has named Steve Terjeson vice president of technology, handing a former WPP Choreograph executive the job of leading its software development and data engineering teams. The assignment is not vague: push AI innovation, make the proprietary...

Continue Reading
TOP-REAL Tests Digital Monitoring in HER2 Cancer Care

Updated Category News Views 116

A cancer treatment can be extraordinarily potent and still get derailed by what happens on an ordinary Tuesday at home. That unglamorous gap between clinic visits is the whole point of TOP-REAL, a phase II academic study presented at ESMO AI & Digital Oncology 2026. Solti and its European partners are testing whether closer digital follow-up can catch trouble early enough...

Continue Reading
New York's $1.2M Prison Abuse Deal Raises State Stakes

Updated Category News Views 41

One courtroom result can expose a whole warehouse of institutional neglect, and this one lands with a grim thud. New York has agreed to pay $1.2 million to resolve a claim involving sexual assault by a former corrections officer at Bayview Correctional Facility in Manhattan. The settlement came after a two-week Adult Survivors Act bellwether trial concluded on November 17...

Continue Reading
Sports Leagues Confront Youth Gambling's Hard Truth

Updated Category News Views 7

A stadium-sized advertising machine cannot pretend kids are not watching. That is the uncomfortable backdrop to the National Council on Problem Gambling's November 10 youth gambling prevention summit, where representatives from the NFL, MLB, NBA and PGA Tour met at the NFL's New York offices. Good that they showed up. Frankly, with gambling stitched into so much sports...

Continue Reading

Top 5 Most Recently Viewed Articles

Amazon.com Options Insights: Market Sentiment Shifts in Focus

Updated Category News Views 299

Amazon.com Options Insights: Market Sentiment Shifts in Focus Investors are showing a notable optimistic stance towards Amazon.com (NASDAQ: AMZN), and ignoring this momentum would be unwise. Recent insights into options trading reveal significant movements that could signal important changes ahead. Our analysis of options data indicates that a substantial number of trades...

Continue Reading
Global Job Vacancies Decline Amid Economic Uncertainty

Updated Category News Views 278

Global Job Vacancies Experience a Notable Decrease LONDON - A recent survey highlights a decline in white-collar job vacancies worldwide, attributed to various factors such as the U.S. election, uncertainty around tax increases in the U.K., and escalating geopolitical tensions. Insights from the Recruitment Sector The monthly Global Jobs Index released by recruitment...

Continue Reading
Jura Energy Corporation Releases Interim Financial Statements

Updated Category News Views 194

Jura Energy Corporation Announces Interim Filings Release Jura Energy Corporation has announced the filing of its condensed consolidated interim financial statements as of June 30, 2024. This report details the company's financial performance for the three and six months leading up to this date. The information is available on SEDAR, along with the Management’s...

Continue Reading
Understanding the Recent Short Interest Trends for Sun Communities

Updated Category News Views 127

Analyzing Sun Communities' Short Interest Dynamics Sun Communities (NYSE: SUI) recently reported a notable change in its short interest percentage, which has seen a decrease of 5.23% since the latest report. The data indicates that currently, there are 1.38 million shares sold short, representing 1.45% of the company’s publicly available shares for trading. This...

Continue Reading
Concentric Energy Advisors Expands Team with Industry Expert

Updated Category News Views 296

Concentric Energy Advisors Welcomes New Expertise Concentric Energy Advisors, Inc. is excited to announce a significant addition to its team. The firm proudly introduces Ms. Christine Saball as the new Assistant Vice President. Recognized for her extensive background in management consulting services for the North American energy sector, Ms. Saball brings over twenty...

Continue Reading